Medtronic PLC annual ebitda for fiscal TTM was $9.7 billion, a decrease of 0.9% from $9.8 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| EBITDA (annual) | TTM → 2026-04-30 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 | 2016-04-30 | 2015-04-30 | 2014-04-30 | 2013-04-30 | 2012-04-30 | 2011-04-30 | 2010-04-30 | 2009-04-30 | 2008-04-30 | 2007-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | $9.7B | $9.8B | $9.2B | $8.2B | $8.7B | $8.8B | $7.5B | $7.8B | $9.3B | $9.5B | $8.6B | $8.5B | $5.5B | $4.9B | $5.5B | $5.3B | $4.9B | $5.1B | $3.5B | $3.8B | $4.3B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EBITDA (quarterly) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|---|---|---|---|
| EBITDA | $2.6B | $2.5B | $2.4B | $2.2B | $2.3B | $2.4B | $2.4B | $2.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MDT metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding
All MDT financial statements → Interactive MDT charts →
About TickerBase · Data methodology & sources